January 2014
Reactions Weekly;1/11/2014, Issue 1483, p45
The article presents a case study of five multiple sclerosis patients who had positive neurologic phenomena and seizures after ingestion of dalfampridine to treat multiple sclerosis.


Related Articles

  • Fampridine May Improve Walking and Quality of Life in Patients With MS.  // Neurology Reviews;Nov2015, Vol. 23 Issue 11, p46 

    The article reports that according to a research, prolonged-release fampridine improves walking and quality of life in patients with multiple sclerosis (MS) and states that side effects of trials of fampridine included insomnia, urinary tract infections, dizziness and headaches.

  • Multiple sclerosis.  // Formulary;Dec2008, Vol. 43 Issue 12, p464 

    The article presents a list of new drugs for multiple sclerosis including dirucotide, fampridine and teriflunomide.

  • Fampridine.  // Reactions Weekly;11/13/2010, Issue 1327, p17 

    The article describes the clinical cases of two patients who developed akathisia while receiving fampridine for multiple sclerosis.

  • Fampridine.  // Reactions Weekly;10/20/2012, Issue 1424, p27 

    The article describes the case of a 37-year-old male patient who developed a toxidrome following fampridine ingestion.

  • Acorda Therapeutics reports results of Fampridine-SR clinical trials.  // PharmaWatch: CNS;June 2004, Vol. 3 Issue 6, p8 

    Reports on the release of Acorda Therapeutics Inc.'s results of both a phase II clinical trial of Fampridine-SR in people with multiple sclerosis. Improvement in walking speed and leg muscle strength of patients receiving Fampridine-SR; Evaluation of the safety and efficacy of Fampridine-SR;...

  • Fampridine.  // Reactions Weekly;6/23/2012, Issue 1407, p24 

    The article describes the cases of six patients with multiple sclerosis (MS) who developed various toxicities while receiving fampridine.

  • Fampridine overdose.  // Reactions Weekly;7/4/2009, Issue 1259, p17 

    The article discusses the case of a 45-year-old woman who developed an encephalopathy following an accidental fampridine overdose. The patient had secondary progressive multiple sclerosis (MS) and is receiving treatment with fampridine. She ingested 35 milligrams of fampridine in three doses...

  • Fampridine-SR.  // Pharmaceutical Representative;Apr2009, Vol. 39 Issue 4, p9 

    The article presents the clinical trial on the effectiveness of Fampridine-SR from Accorda Therapeutics Inc. It's Phase III trial proved that Fampridine can ameliorate the walking pace of the patients who are succumbed with movement disorders as a complication of multiple sclerosis. Moreover,...

  • Selected literature.  // Formulary;Dec2008, Vol. 43 Issue 12, p464 

    The article presents a list of medical researches on multiple sclerosis, which were published in various journals including a study on a trial of sustained-release fampridine in multiple sclerosis, another study on study of the safety and efficacy of teriflunomide in multiple sclerosis with...

  • Famprindine overdose.  // Reactions Weekly;5/7/2005, Issue 1050, p11 

    Presents a case study involving a man who developed central nervous system disorders resembling limbic encephalitis, along with heart and skeletal muscle disorders, after ingestion of a fampridine overdose. Dosage of fampridine taken by the patient; Results of cerebrospinal fluid examination...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics